REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden ...
"Implementing CSA for GxP Systems - Transition, Documentation, and Post-Transition Challenges and Opportunities" training has been added to ResearchAndMarkets.com's offering. The transition to ...
The SPAR Group Ltd ( SGPPY) Q4 2025 Earnings Call December 8, 2025 2:30 AM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results